Please try another search
YTD | 3M | 1Y | 3Y | 5Y | 10Y | |
---|---|---|---|---|---|---|
Growth of 1000 | 1007 | 1026 | 1047 | 1073 | 1421 | 1506 |
Fund Return | 0.73% | 2.56% | 4.74% | 2.39% | 7.28% | 4.18% |
Place in category | 641 | 533 | 603 | 168 | 69 | 192 |
% in Category | 87 | 70 | 86 | 30 | 11 | 50 |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
Federated Strategic Value Dividend | 4.58B | 1.26 | 5.23 | 6.02 | ||
Federated Kaufmann R | 3.41B | 4.37 | -5.19 | 8.92 | ||
Federated Kaufmann Small Cap Instl | 2.43B | 1.53 | -7.95 | - | ||
Federated Strategic Value DividendA | 1.47B | 1.19 | 5.00 | 5.76 | ||
Federated Kaufmann A | 1.09B | 4.19 | -5.21 | 8.92 |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
Vanguard Total Intl Stock Index Inv | 191.19B | 1.91 | 0.13 | 4.01 | ||
Vanguard Total Intl Stock Index Adm | 73.1B | 1.95 | 0.19 | 4.07 | ||
Fidelity International Index Inst | 48.57B | 2.55 | 2.86 | 4.45 | ||
Fidelity Series Global ex US Index | 44.6B | 2.31 | 0.29 | 3.89 | ||
Vanguard Total Intl Stock Index I | 39.57B | 1.98 | 0.22 | 4.10 |
Name | ISIN | Weight % | Last | Change % | |
---|---|---|---|---|---|
AstraZeneca | GB0009895292 | 3.79 | 12,346.0 | +1.28% | |
Siemens AG | DE0007236101 | 3.06 | 178.16 | +1.08% | |
Novo Nordisk B | DK0062498333 | 2.90 | 923.9 | -0.37% | |
ASML Holding | NL0010273215 | 2.50 | 880.50 | +1.11% | |
Sanofi | FR0000120578 | 2.48 | 90.11 | +0.39% |
Type | Daily | Weekly | Monthly |
---|---|---|---|
Moving Averages | Buy | Strong Buy | Buy |
Technical Indicators | Strong Sell | Strong Buy | Strong Buy |
Summary | Neutral | Strong Buy | Strong Buy |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review